Federal Register / Vol. 77, No. 81 / Thursday, April 26, 2012 / Notices 24969 

NCI should support requests and make 

available contract resources for 

development of the potential 

therapeutic to improve the treatment of 

various forms of cancer. The research 

proposals and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material and personal information 

concerning individuals associated with 

the proposed research projects, the 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Clinical 

Assay Development Program (CADP). 

Date: July 31, 2012. 

Time: 8 a.m.–3 p.m. 

Agenda: To review grant applications for 

the CADP. 

Place: National Cancer Institute, NIH, 

Executive Plaza North, 6130 Executive 

Boulevard, Room J, Rockville, MD 20852. 

Contact Person: Tracy G. Lively, Ph.D., 

Executive Secretary, Cancer Diagnosis 

Program (CADP), National Cancer Institute, 

NIH, 6130 Executive Boulevard, EPN/6035A, 

Bethesda, MD 20892, 301–496–8639, 

livelyt@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: April 19, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–10083 Filed 4–25–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group; Subcommittee 

I—Career Development. 

Date: June 12–13, 2012. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Sergei Radaev, Ph.D., 

Scientific Review Officer, Resources and 

Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., RM 

8113, Bethesda, MD 20892, 301–435–5655, 

sradaev@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/irg/irg.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: April 19, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–10082 Filed 4–25–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Initial Review Group; Behavior and 

Social Science of Aging Review Committee. 

Date: June 6–7, 2012. 

Time: 3 p.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marina del Rey Hotel, 13534 Bali 

Way, Marina del Rey, CA 90292. 

Contact Person: Jeannette L. Johnson, 

Ph.D., Scientific Review Officer, National 

Institutes on Aging, National Institutes of 

Health, 7201 Wisconsin Avenue, Suite 

2C212, Bethesda, MD 20892, 301–402–7705, 

johnsonj9@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Initial Review Group; Biological Aging 

Review Committee. 

Date: June 6–7, 2012. 

Time: 3 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marina del Rey Hotel, 13534 Bali 

Way, Marina del Rey, CA 90292. 

Contact Person: Bita Nakhai, Ph.D., 

Scientific Review Branch, National Institute 

on Aging, Gateway Bldg., 2C212, 7201 

Wisconsin Avenue, Bethesda, MD 20814, 

301–402–7701, nakhaib@nia.nih.gov 

Name of Committee: National Institute on 

Aging Initial Review Group; Clinical Aging 

Review Committee. 

Date: June 7–8, 2012. 

Time: 12 p.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marina del Rey Hotel, 13534 Bali 

Way, Marina del Rey, CA 90292. 

Contact Person: Alicja L. Markowska, 

Ph.D., DSC, National Institute on Aging, 

National Institutes of Health, Gateway 

Building 2C212, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, 301–496–9666, 

markowsa@nia.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 

Dated: April 19, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–10081 Filed 4–25–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications/ 

contracts and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 


tkelley on DSK3SPTVN1PROD with NOTICES
24970 Federal Register / Vol. 77, No. 81 / Thursday, April 26, 2012 / Notices 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SBIR Topic 

255 Development of Anticancer Agents 

Meeting I. 

Date: May 14, 2012. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 611, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Shakeel Ahmad, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 8139, 

Bethesda, MD 20892–8328, (301) 594–0114, 

ahmads@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SBIR Topic 

255 Development of Anticancer Agents 

Meeting II. 

Date: May 15, 2012. 

Time: 12 p.m. to 3 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 210, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Virginia P. Wray, Ph.D., 

Deputy Chief, Research Programs Review 

Branch, Research Programs Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, NIH, 6116 Executive Blvd., 

Room 8125, Bethesda, MD 20892–8328, 301– 

496–9236, wrayv@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SPORE in 

Breast, Prostate and Thyroid Cancers. 

Date: May 23–24, 2012. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, Montgomery County 

Conference Center Facility, 5701 Marinelli 

Road, North Bethesda, MD 20852. 

Contact Person: Wlodek Lopaczynski, MD, 

Ph.D., Scientific Review Officer, Research 

Programs Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., Room 

8131, Bethesda, MD 20892, 301–594–1402, 

lopacw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project Review Panel Meeting IV. 

Date: June 11–12, 2012. 

Time: 3 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Majed M. Hamawy, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Boulevard, Room 8135, 

Bethesda, MD 20892, 301–594–5659, 

mh101v@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project Review Panel Meeting II. 

Date: June 13–14, 2012. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 

(Formerly Holiday Inn Select), 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Delia Tang, MD, Scientific 

Review Officer, Research Programs Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, NIH, 6116 

Executive Blvd., Room 8123, Bethesda, MD 

20892, 301–496–2330, tangd@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; NCI 

Program Project Review Panel Meeting I. 

Date: June 14–15, 2012. 

Time: 8 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: DoubleTree Hotel and Executive 

Meeting Center; 8120 Wisconsin Ave., 

Bethesda, MD 20814. 

Contact Person: David G. Ransom, Ph.D., 

Scientific Review Officer, Research Programs 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, NIH, 

6116 Executive Blvd., Room 8133, Bethesda, 

MD 20892–8328, 301–451–4757, 

david.ransom@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Small 

Grants Program for Cancer Epidemiology. 

Date: June 21–22, 2012. 

Time: 8:30 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Joyce C. Pegues, Ph.D., 

Scientific Review Officer, Special Review 

and Logistics Branch, Division of Extramural 

Activities, NIH National Cancer Institute, 

NIH, 6116 Executive Boulevard, Room 7149, 

Bethesda, MD 20892–8329, 301–594–1286, 

peguesj@mail.nih.gov. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

deainfo.nci.nih.gov/advisory/sep/sep.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: April 19, 2012. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2012–10079 Filed 4–25–12; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Fast 

Fail—Experimental Medicines Contracts— 

Mood and Anxiety Disorders. 

Date: May 22, 2012. 

Time: 1 p.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: David I. Sommers, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

6001 Executive Blvd., Room 6154, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–7861, 

dsommers@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Fast 

Fail—Experimental Medicines Contracts— 

Autism. 

Date: May 24, 2012. 

Time: 1 p.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: David I. Sommers, Ph.D., 

Scientific Review Officer, Division of 

Extramural Activities, National Institute of 

Mental Health, National Institutes of Health, 

6001 Executive Blvd., Room 6154, MSC 9606, 

Bethesda, MD 20892–9606, 301–443–7861, 

dsommers@mail.nih.gov. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; Fast 

Fail—Experimental Medicines Contracts— 

Psychotic Spectrum. 

Date: May 25, 2012. 

Time: 1 p.m. to 6 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 


tkelley on DSK3SPTVN1PROD with NOTICES